Research Summary

Dr. Ryutaro Hirose is a transplant surgeon who performs liver, kidney and pancreas transplants.

Hirose's research interests include the induction of immunologic tolerance, immune monitoring and cancer in transplant patients. He has received research grants from the National Kidney Foundation and UCSF School of Medicine.

Hirose earned his medical degree from Vagelos College of Physicians and Surgeons, the medical school of Columbia University. He completed clinical research training at UCSF as a resident in general surgery and a fellow in molecular medicine and transplantation surgery.

Hirose is involved in teaching medical students as well as residents and fellows in surgery. He serves as associate director of UCSF's general surgery residency program.

Education

2019 - Diversity, Equity, and Inclusion Champion Training, University of California
Residency, - School of Medicine, University of California, San Francisco

Selected Publications

  1. Meier RPH, Nunez M, Syed SM, Feng S, Tavakol M, Freise CE, Roberts JP, Ascher NL, Hirose R, Roll GR. DCD liver transplant in patients with a MELD over 35. Front Immunol. 2023; 14:1246867.  View on PubMed
  2. Yilma M, Cogan R, Shui AM, Neuhaus JM, Light C, Braun H, Mehta N, Hirose R. Community-level social vulnerability and individual socioeconomic status on liver transplant referral outcome. Hepatol Commun. 2023 07 01; 7(7).  View on PubMed
  3. Yilma M, Dalal N, Wadhwani SI, Hirose R, Mehta N. Geographic disparities in access to liver transplantation. Liver Transpl. 2023 09 01; 29(9):987-997.  View on PubMed
  4. Snyder JJ, Schaffhausen CR, Hart A, Axelrod DA, Dils D, Formica RN, Gaber AO, Hunt HF, Jones J, Mohan S, Patzer RE, Pinney SP, Ratner LE, Slaker D, Stewart D, Stewart ZA, Van Slyck S, Kasiske BL, Hirose R, Israni AK. Stakeholders' perspectives on transplant metrics: the 2022 Scientific Registry of Transplant Recipients' consensus conference. Am J Transplant. 2023 07; 23(7):875-890.  View on PubMed
  5. Hart A, Patzer RE, Spear J, Hirose R, Tabatabai A, Wood NL, Schaffhausen CR, Axelrod DA, Israni AK, Snyder JJ. Time to discard the term "discard". Am J Transplant. 2023 05; 23(5):608-610.  View on PubMed
  6. Miller JM, Ahn YS, Hart A, Lindblad K, Jett C, Fox C, Hirose R, Israni AK, Snyder JJ. OPTN/SRTR 2021 Annual Data Report: COVID-19. Am J Transplant. 2023 02; 23(2 Suppl 1):S475-S522.  View on PubMed
  7. Brown AE, Shui AM, Adelmann D, Mehta N, Roll GR, Hirose R, Syed SM. Number of Local Regional Therapies for Hepatocellular Carcinoma and Peri-Operative Outcomes after Liver Transplantation. Cancers (Basel). 2023 Jan 19; 15(3).  View on PubMed
  8. Hirose R. Toward a better distribution system: it is complicated. Liver Transpl. 2023 01 01; 29(1):1-2.  View on PubMed
  9. Domínguez-Gil B, Ascher NL, Fadhil RAS, Muller E, Cantarovich M, Ahn C, Berenguer M, Bušic M, Egawa H, Gondolesi GE, Haberal M, Harris D, Hirose R, Ilbawi A, Jha V, López-Fraga M, Andrés Madera S, Najafizadeh K, O'Connell PJ, Rahmel A, Shaheen FAM, Twahir A, Van Assche K, Wang H, Haraldsson B, Chatzixiros E, Delmonico FL. The Reality of Inadequate Patient Care and the Need for a Global Action Framework in Organ Donation and Transplantation. Transplantation. 2022 11 01; 106(11):2111-2117.  View on PubMed
  10. Greenberg AL, Karimzada MM, Brian R, Yap A, Luu HY, Ahmed S, Huang CY, Waits SA, Hirose R, Alseidi A, Rapp JH, O'Sullivan PS, Chern H, Syed SM. Assessment of Surgeon Performance of Advanced Open Surgical Skills Using a Microskills-Based Novel Curriculum. JAMA Netw Open. 2022 09 01; 5(9):e2229787.  View on PubMed
  11. Miller J, Lyden GR, Zaun D, Kasiske BL, Hirose R, Israni AK, Snyder JJ. Transplant program evaluations in the middle of the COVID-19 pandemic. Am J Transplant. 2022 11; 22(11):2616-2626.  View on PubMed
  12. Israni AK, Hirose R, Segev DL, Hart A, Schaffhausen CR, Axelrod DA, Kasiske BL, Snyder JJ. Toward continuous improvement of Scientific Registry of Transplant Recipients performance reporting: Advances following 2012 consensus conference and future consensus building for 2022 consensus conference. Clin Transplant. 2022 07; 36(7):e14716.  View on PubMed
  13. Amara D, Hansen KS, Kupiec-Weglinski SA, Braun HJ, Hirose R, Hilton JF, Rickels MR, Odorico JS, Stock PG. Pancreas Transplantation for Type 2 Diabetes: A Systematic Review, Critical Gaps in the Literature, and a Path Forward. Transplantation. 2022 10 01; 106(10):1916-1934.  View on PubMed
  14. Amara D, Parekh J, Sudan D, Elias N, Foley DP, Conzen K, Grieco A, Braun HJ, Greenstein S, Byrd C, Ko C, Hirose R. Surgical complications after living and deceased donor liver transplant: The NSQIP transplant experience. Clin Transplant. 2022 06; 36(6):e14610.  View on PubMed
  15. Zarinsefat A, Gulati A, Shui A, Braun H, Rogers R, Hirose R, Ascher N, Stock P. Long-term Outcomes Following Kidney and Liver Transplant in Recipients With HIV. JAMA Surg. 2022 03 01; 157(3):240-247.  View on PubMed
  16. Roll GR, Hirose R. Toward a more efficient organ placement system (and defeating FOMO). Am J Transplant. 2022 06; 22(6):1511-1512.  View on PubMed
  17. Braun HJ, Amara D, Shui AM, Stock PG, Hirose R, Delmonico FL, Ascher NL. International Travel for Liver Transplantation: A Comprehensive Assessment of the Impact on the United States Transplant System. Transplantation. 2022 02 01; 106(2):e141-e152.  View on PubMed
  18. Miller J, Wey A, Valapour M, Hart A, Musgrove D, Hirose R, Ahn YS, Israni AK, Snyder JJ. Impact of COVID-19 pandemic on the size of US transplant waiting lists. Clin Transplant. 2022 05; 36(5):e14596.  View on PubMed
  19. Meier RPH, Kelly Y, Yamaguchi S, Braun HJ, Lunow-Luke T, Adelmann D, Niemann C, Maluf DG, Dietch ZC, Stock PG, Kang SM, Feng S, Posselt AM, Gardner JM, Syed SM, Hirose R, Freise CE, Ascher NL, Roberts JP, Roll GR. Advantages and Limitations of Clinical Scores for Donation After Circulatory Death Liver Transplantation. Front Surg. 2021; 8:808733.  View on PubMed
  20. Bernards S, Hirose R, Yao FY, Jin C, Dodge JL, Huang CY, Mehta N. The Impact of Median Model for End-Stage Liver Disease at Transplant Minus 3 National Policy on Waitlist Outcomes in Patients With and Without Hepatocellular Carcinoma. Liver Transpl. 2022 03; 28(3):376-385.  View on PubMed

Go to UCSF Profiles, powered by CTSI